A Randomized, Single‐dose, Phase I Clinical Comparison of a Trastuzumab Biosimilar With a Reference Trastuzumab Formulation in Healthy Chinese Male Volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Randomized, Single‐dose, Phase I Clinical Comparison of a Trastuzumab Biosimilar With a Reference Trastuzumab Formulation in Healthy Chinese Male Volunteers

Published:2022-11 Issue:2 Volume:12 Page:181-189
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Pu Huahua¹²,Jia Jingying¹²,Zhao Chunyang¹²,Hou Sheng³,Guo Huaizu⁴,Li Jing⁴,Qian Weizhu⁴,Wang Hao⁴,Sun Chan¹²,Zou Yang¹²

Affiliation:

1. Central Laboratory Shanghai Xuhui Central Hospital/Zhongshan‐Xuhui Hospital Fudan University Shanghai China

2. Shanghai Engineering Research Center of Phase I Clinical Research and Quality Consistency Evaluation for Drugs Shanghai China

3. Shanghai Zhangjiang Biotechnology Co., Ltd Shanghai China

4. Taizhou Mabtech Pharmaceuticals Co., Ltd Jiangsu China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1189

Reference20 articles.

1. Breast Cancer Statistics, 2022

2. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

3. Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030

4. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

5. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP